[go: up one dir, main page]

UA95224C2 - Антацидная фармацевтическая композиция в порошковой форме, фармацевтическое средство, ее содержащее, и способ ее получения - Google Patents

Антацидная фармацевтическая композиция в порошковой форме, фармацевтическое средство, ее содержащее, и способ ее получения

Info

Publication number
UA95224C2
UA95224C2 UAA200706189A UAA200706189A UA95224C2 UA 95224 C2 UA95224 C2 UA 95224C2 UA A200706189 A UAA200706189 A UA A200706189A UA A200706189 A UAA200706189 A UA A200706189A UA 95224 C2 UA95224 C2 UA 95224C2
Authority
UA
Ukraine
Prior art keywords
acid
sodium alginate
powder form
pharmaceutical composition
inhibitor
Prior art date
Application number
UAA200706189A
Other languages
English (en)
Ukrainian (uk)
Inventor
Марио Атилио Лос
Original Assignee
Лабораториос Баго С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лабораториос Баго С.А. filed Critical Лабораториос Баго С.А.
Publication of UA95224C2 publication Critical patent/UA95224C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение касается антацидной фармацевтической композиции для быстрой и продолжительной нейтрализации кислотности желудка с защитным действием по отношению к слизистой оболочке желудка в виде порошка, для приготовления, путем растворения в воде, фармацевтического раствора или суспензии для перорального применения. Композиция содержит альгинат натрия, растворимый антацидный агент или комбинацию антацидов, ингибитор протонного насоса, разбавитель и подсластители, где (а) от 20 % до 30 % альгината натрия, присутствующего в композиции вместе с суммарным количеством ингибитора протонного насоса, гомогенно распределены по поверхности всего антацидного агента или комбинации антацидов композиции, и (b) другое количество, близко 70 %, альгината натрия, присутствующего в композиции, имеет влажность менее 2 %.
UAA200706189A 2006-06-05 2007-06-04 Антацидная фармацевтическая композиция в порошковой форме, фармацевтическое средство, ее содержащее, и способ ее получения UA95224C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP060102333A AR056062A1 (es) 2006-06-05 2006-06-05 Composicion farmaceutica antiacida en forma de polvo, preparacion farmaceutica que la comprende y proceso para su preparacion

Publications (1)

Publication Number Publication Date
UA95224C2 true UA95224C2 (ru) 2011-07-25

Family

ID=38572778

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200706189A UA95224C2 (ru) 2006-06-05 2007-06-04 Антацидная фармацевтическая композиция в порошковой форме, фармацевтическое средство, ее содержащее, и способ ее получения

Country Status (11)

Country Link
US (2) US7968118B2 (ru)
EP (1) EP1905426B1 (ru)
AR (1) AR056062A1 (ru)
BR (1) BRPI0704028B8 (ru)
DE (1) DE07380159T1 (ru)
ES (1) ES2301455T3 (ru)
MX (1) MX2007006722A (ru)
PL (1) PL1905426T3 (ru)
RU (1) RU2351332C2 (ru)
UA (1) UA95224C2 (ru)
UY (1) UY30382A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008019339A1 (de) * 2008-04-16 2009-10-22 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum
AU2011242177B8 (en) * 2010-04-23 2015-06-04 S-Biotek Holding Aps A solid pharmaceutical composition for neutralizing stomach acid
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
TR201723199A2 (tr) * 2017-12-30 2019-07-22 Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi Yeni farmasötik bileşimler.
TW202126301A (zh) * 2019-10-04 2021-07-16 愛爾蘭商席歐拉斯製藥有限公司 小兒懸浮調配物
FR3107183B1 (fr) * 2020-02-19 2022-04-29 Amsellem Jean Paul Composition pour le traitement des vertiges
CN114288243B (zh) * 2022-01-24 2023-02-07 中国药科大学 一种口服抗酸原位凝胶及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744986A (en) * 1986-03-07 1988-05-17 Rorer Pharmaceutical Corporation Process for the preparation of a viscosity-stable antacid composition
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
AU7218294A (en) * 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-alginate combinations
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
WO1998023272A1 (en) * 1996-11-27 1998-06-04 The Procter & Gamble Company Compositions and methods for the treatment of gastrointestinal disorders
BR0300882A (pt) * 2003-04-09 2005-05-10 Cmax Otimizacao De Resultados Composições farmacêuticas, método e uso de formulação para tratamento e prevenção de infecções associadas com helicobacter pylori em mamìferos e no ser humano
CA2531566C (en) * 2003-07-18 2013-05-07 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
EP1667681A4 (en) * 2003-10-03 2009-09-30 Astron Res Pvt Ltd NEW TRANSMUCOSAL ADMINISTRATION SYSTEM

Also Published As

Publication number Publication date
US20100160382A1 (en) 2010-06-24
MX2007006722A (es) 2009-02-18
BRPI0704028B8 (pt) 2022-05-10
ES2301455T3 (es) 2013-01-23
BRPI0704028B1 (pt) 2021-02-09
RU2007120753A (ru) 2008-12-10
BRPI0704028A (pt) 2008-04-01
RU2351332C2 (ru) 2009-04-10
PL1905426T3 (pl) 2013-02-28
EP1905426B1 (en) 2012-09-05
EP1905426A3 (en) 2008-05-21
EP1905426A2 (en) 2008-04-02
US20070281015A1 (en) 2007-12-06
DE07380159T1 (de) 2008-08-21
US7968118B2 (en) 2011-06-28
ES2301455T1 (es) 2008-07-01
US8093271B2 (en) 2012-01-10
UY30382A1 (es) 2007-07-31
AR056062A1 (es) 2007-09-19

Similar Documents

Publication Publication Date Title
UA95224C2 (ru) Антацидная фармацевтическая композиция в порошковой форме, фармацевтическое средство, ее содержащее, и способ ее получения
MY143795A (en) Tetrahydropyridoindole derivatives
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
IL190400A (en) Amphiphilic polymers of chemically and physically stable and water-soluble pdgf polymer, methods of making them, therapeutics containing them, and their use in the preparation of topical ulcer preparations
MX2010006371A (es) Producto para el cuidado oral y metodos de uso y fabricacion del mismo.
MY157944A (en) Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associat ed with angiogenesis
MX2009012000A (es) Derivados de pirazol heteroarilo sustituidos utiles para el tratamiento de trastornos hiperproliferativos y enfermedades asociadas a la angiogenesis.
EA018193B3 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
MY151071A (en) Low-foaming preparations for crop protection
NZ585219A (en) Fast release solid formulation, preparation and use thereof
UA98804C2 (ru) Катехоламиновые производные и фармацевтическая композиция на их основе
UA104888C2 (ru) Адъювантная композиция, которая содержит неионный изотонический агент
TW200733968A (en) Stabilized lanthanum carbonate compositions
SI1933809T1 (sl) Sestavki za mazalno dajanje
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
WO2010041832A3 (ko) 패 유래 화합물 함유 항산화 활성 조성물
TW200501965A (en) Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle
TW200633978A (en) 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists
WO2007087623A3 (en) Methods and compositions for treating feline hyperthyroidism
WO2007002836A3 (en) Methods and compositions for the prevention and treatment of kidney disease
TW200727903A (en) Stable pharmaceutical compositions of 5, 10 methylenetetrahydrofolate
SG179131A1 (en) Modified erythropoietin to which water-soluble long-chain molecule is added
TW200800977A (en) A new salt
TW200621773A (en) Bicyclononene derivatives
WO2009008461A1 (ja) 性ホルモン感受性細胞増殖を原因とする疾患に対する医薬組成物